Quigley EM, Wald A, Fidelholtz J, et al. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies. Clin Gastroenterol Hepatol. 2006;4:605-613.

Tegaserod was stable in this medium for up to three days at 20-25 °C or 5 °C, and the dissolution profile of a crushed tablet in water was the same as that of the intact tablet.

Patient responses to tegaserod treatment for the outcome measure of PVR urine volume can be found in Figure 1 and Table 2. After tegaserod treatment, the average PVR was significantly reduced when ...